Since the pioneering NCI-60 panel of the late'80's, several major screenings of genetic profiling and drug testing in cancer cell lines have been conducted to investigate how genetic backgrounds and transcriptional patterns shape cancer's response to therapy and to identify disease-specific genes associated with drug response. Historically, pharmacogenomics screenings have been largely heterogeneous in terms of investigated cell lines, assay technologies, number of compounds, type and quality of genomic data, and methods for their computational analysis. The analysis of this enormous and heterogeneous amount of data required the development of computational methods for the integration of genomic profiles with drug responses across multiple screenings. Here, we will review the computational tools that have been developed to integrate cancer cell lines' genomic profiles and sensitivity to small molecule perturbations obtained from different screenings.

Computational Methods for the Integrative Analysis of Genomics and Pharmacological Data / Caroli, J.; Dori, M.; Bicciato, S.. - In: FRONTIERS IN ONCOLOGY. - ISSN 2234-943X. - 10:(2020), pp. 1-6. [10.3389/fonc.2020.00185]

Computational Methods for the Integrative Analysis of Genomics and Pharmacological Data

Caroli J.;Dori M.;Bicciato S.
2020

Abstract

Since the pioneering NCI-60 panel of the late'80's, several major screenings of genetic profiling and drug testing in cancer cell lines have been conducted to investigate how genetic backgrounds and transcriptional patterns shape cancer's response to therapy and to identify disease-specific genes associated with drug response. Historically, pharmacogenomics screenings have been largely heterogeneous in terms of investigated cell lines, assay technologies, number of compounds, type and quality of genomic data, and methods for their computational analysis. The analysis of this enormous and heterogeneous amount of data required the development of computational methods for the integration of genomic profiles with drug responses across multiple screenings. Here, we will review the computational tools that have been developed to integrate cancer cell lines' genomic profiles and sensitivity to small molecule perturbations obtained from different screenings.
2020
10
1
6
Computational Methods for the Integrative Analysis of Genomics and Pharmacological Data / Caroli, J.; Dori, M.; Bicciato, S.. - In: FRONTIERS IN ONCOLOGY. - ISSN 2234-943X. - 10:(2020), pp. 1-6. [10.3389/fonc.2020.00185]
Caroli, J.; Dori, M.; Bicciato, S.
File in questo prodotto:
File Dimensione Formato  
Caroli_et_al_FrontOncology_2020.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 649.76 kB
Formato Adobe PDF
649.76 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1247656
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 7
social impact